-
Sector Analysis
Personal Protective Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Personal Protective Equipment Market Report Overview The personal protective equipment market size was $48.35 billion in 2023. Factors such as the increasing volume of surgeries per year and technological advancement will drive the market growth at a CAGR of more than 7% during 2023-2033. Personal Protective Equipment (PPE) devices are used to minimize healthcare workers’ exposure to infectious agents. It will also help to maintain sterile environments when providing treatments to patients. PPE is required when medical procedures are performed...
-
Thematic Analysis
NewCloud Computing – Thematic Intelligence
Cloud Computing Thematic Report Overview The cloud services sector competes to provide the best artificial intelligence (AI) platforms and services, partly catalyzed by the emergence of generative AI. AI is now central to the cloud services market, from developing custom chips and supporting workloads and providing the models and tools necessary to develop AI-enabled solutions. The Cloud Computing  thematic intelligence report provides an overview of the cloud computing theme. It identifies the key trends impacting the growth of the theme...
-
Product Insights
Hyperphosphatemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Hyperphosphatemia - Drugs In Development, 2023’, provides an overview of the Hyperphosphatemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperphosphatemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Hyperphosphatemia In Chronic Kidney Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Drugs In Development, 2023’, provides an overview of the Hyperphosphatemia In Chronic Kidney Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperphosphatemia In Chronic Kidney Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Botulism – Drugs In Development, 2023
Global Markets Direct’s, ‘Botulism - Drugs In Development, 2023’, provides an overview of the Botulism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Botulism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Iron Deficiency Anemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Iron Deficiency Anemia - Drugs In Development, 2023’, provides an overview of the Iron Deficiency Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Iron Deficiency Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview The colorectal cancer screening Tests pipeline market research report provides comprehensive information about the colorectal cancer screening tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Other Colorectal Cancer Screening Tests ·       Fecal DNA Test Kits ·       Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits Key Territories ·       The US ·       Europe...
-
Product Insights
NewClot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...
-
Thematic Analysis
Advertising Sector Scorecard, Q3 2023 Update – Thematic Intelligence
US Big Tech, specifically Microsoft, Apple, Amazon, and Alphabet, dominate the thematic screen of GlobalData’s advertising sector scorecard. Thanks to their sophisticated AI systems, advanced advertising technology (adtech), and the wealth of data they possess, they are best placed to reap the benefits of disruptive themes like AI, gaming, and ecommerce. But these companies will also have regulators breathing down on their necks on several issues, from antitrust and data privacy to misinformation and online harm. For example, while top...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-20 in Hyperphosphatemia In Chronic Kidney Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-20 in Hyperphosphatemia In Chronic Kidney Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-20 in Hyperphosphatemia In Chronic Kidney Disease Drug Details:...